Alesco Surgipharma Private Limited

Manufactures and trades pharmaceutical, surgical, healthcare, and dietary products.

2021 | Bhopal, Madhya Pradesh (India) | Active
Last Updated:

Alesco Surgipharma Profile

Key Indicators

  • Authorised Capital ₹ 2.00 Cr
  • Paid Up Capital ₹ 1.89 Cr
  • Company Age 3 Year, 7 Months
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 15.00 Cr
  • Revenue Growth %
  • Profit Growth -285.79%
  • Ebitda -285.79%
  • Net Worth -11.93%
  • Total Assets 18.42%

About Alesco Surgipharma

Alesco Surgipharma Private Limited (ASPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 02 September 2021 (Three years and seven months 11 days old ). Its registered office is in Bhopal, Madhya Pradesh, India.

The Company is engaged in the Healthcare Industry.

The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 1.89 Cr.

The company currently has active open charges totaling ₹15.00 Cr.

Manoj Modi and Ishita Modi serve as directors at the Company.

Company Details

  • Location

    Bhopal, Madhya Pradesh, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address

  • Website

  • Social Media

Corporate Identity Details

  • CIN/LLPIN

    U33112MP2021PTC057325

  • Company No.

    057325

  • Company Classification

    Private Limited Indian Non-Government Company

  • Incorporation Date

    02 Sep 2021

  • Date of AGM

    30 Sep 2024

  • Date of Balance Sheet

    31 Mar 2024

  • Listing Status

    Unlisted

  • ROC Code

    Roc Gwalior

Industry

Healthcare
Pharma
Company report

Alesco Surgipharma Private Limited

Explore comprehensive data for Alesco Surgipharma Private Limited, including financials, compliance details, shareholding patterns, and litigation history.

Who are the key members and board of directors at Alesco Surgipharma?

Board Members (2)

NameDesignationAppointment DateStatus
Ishita Modi Country flag representing In Director 10-Apr-2024Current
Manoj Modi Country flag representing In Director 04-Sep-2021Current

Financial Performance of Alesco Surgipharma.

Alesco Surgipharma Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 285.79% decrease in profit. The company's net worth observed a substantial decline by a decrease of 11.93%.

Alesco Surgipharma revenue growth over time
Alesco Surgipharma profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
Revenue from Operations
Total Assets
18.42%
Profit or Loss
-285.79%
Net Worth
-11.93%
EBITDA
-285.79%

What is the Ownership and Shareholding Structure of Alesco Surgipharma?

In 2023, Alesco Surgipharma had a public holding of 60.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Indicator graph

Charges (Loans)

Open Charges

₹15.00 Cr

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions

  • Hdfc Bank Limited : 15.00 Cr

Latest Charge Details

DateLenderAmountStatus
20 Nov 2023Hdfc Bank Limited₹15.00 CrOpen

How Many Employees Work at Alesco Surgipharma?

Alesco Surgipharma has a workforce of 0 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee growth trends for Alesco Surgipharma Private Limited

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Alesco Surgipharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Alesco Surgipharma's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Alesco Surgipharma

Recent activity within the organization

  • Annual General Meeting

    Alesco Surgipharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.

  • Director Appointment

    Ishita Modi was appointed as a Director was appointed as a Director on 10 Apr 2024 & has been associated with this company since 1 year 3 days .

  • Balance Sheet

    Alesco Surgipharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Gwalior.

  • Charges

    A charge with Hdfc Bank Limited of Rs. 15.00 Cr registered on 20 Nov 2023 with Charge ID 100818167 was modified on 22 Nov 2023.

  • Charges

    A charge with Hdfc Bank Limited amounted to Rs. 15.00 Cr with Charge ID 100818167 was registered on 20 Nov 2023.

  • Director Appointment

    Manoj Modi was appointed as a Director was appointed as a Director on 04 Sep 2021 & has been associated with this company since 3 years 7 months .

Frequently asked questions

  • What is the Incorporation or founding date of Alesco Surgipharma Private Limited?

    Alesco Surgipharma Private Limited was incorporated on 02 Sep 2021.

  • What is authorized share capital and paid-up capital of Alesco Surgipharma Private Limited?

    The authorized share capital of Alesco Surgipharma Private Limited is ₹ 2.00 Cr and paid-up capital is ₹ 1.89 Cr.

  • Who are the current board members & directors of Alesco Surgipharma Private Limited?

    Currently 2 directors are associated with Alesco Surgipharma Private Limited.

    • Manoj Modi
    • Ishita Modi

  • What is the registered address of Alesco Surgipharma Private Limited?

    As per Ministry of Corporate Affairs (Mca), the registered address of Alesco Surgipharma Private Limited is 25/86, Malviya Nagar India, Bhopal, Madhya Pradesh, 462003.

  • What is the corporate identification number (CIN) and company number of Alesco Surgipharma Private Limited?

    The corporate identification number (CIN) of Alesco Surgipharma Private Limited is U33112MP2021PTC057325 and the company number is 057325 as per Ministry of Corporate Affairs (MCA).

  • What change has been observed in the net worth of Alesco Surgipharma Private Limited, and by what percentage?

    The financial reports for the fiscal year 2023 indicates that The net worth of Alesco Surgipharma Private Limited has experienced an downturn of -11.93%.

  • What are the total open charges for Alesco Surgipharma Private Limited?

    As per the financial statements for fiscal Year 2023, The total open charges for Alesco Surgipharma Private Limited amount to ₹ 15.00 Cr.

  • When was the last Balance Sheet of Alesco Surgipharma Private Limited filed with the ROC?

    The most recent Balance Sheet for Alesco Surgipharma Private Limited was filed with the ROC on 31 Mar 2024.

Unlock Business Insights – Explore Instantly!

Search company & director profiles for free and gain access to critical business data.

  • 3.1M+ Companies
  • 15M+ Legal Cases
  • 525K+ Credit Ratings
  • 5.8M+ Directors & KMP
  • 750K+ Regulatory Alerts
  • 1.1M+ Companies' Financial Records
Start Free Trial

People also Viewed

Similar Companies Based on Drug Formulation & Development